Detalhe da pesquisa
1.
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma.
Drug Resist Updat
; 68: 100957, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990047
2.
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.
Cancer Res
; 82(19): 3516-3531, 2022 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193649